Combination Oral Contraceptive Recalled On Fears Of Reduced Effectiveness

Jubilant Cadista Pharmaceuticals is recalling one lot of the combination oral contraceptive Drospirenone and Ethinyl Estradiol Tablets, USP, 3mg/0.02mg. due to the possibility of decreased product” effectiveness. The company disclosed that “the recall is being initiated because of out-of-specification dissolution test results at the three-month stability time point.” Consequently, the effectiveness of the product “may be reduced due to incomplete absorption of the active ingredient.” https://www.endocrinologyadvisor.com/home/topics/general-endocrinology/oral-contraceptive-recalled-due-to-possibility-of-reduced-efficacy/